JPH049336A - Hypnotic agent - Google Patents

Hypnotic agent

Info

Publication number
JPH049336A
JPH049336A JP2111566A JP11156690A JPH049336A JP H049336 A JPH049336 A JP H049336A JP 2111566 A JP2111566 A JP 2111566A JP 11156690 A JP11156690 A JP 11156690A JP H049336 A JPH049336 A JP H049336A
Authority
JP
Japan
Prior art keywords
active ingredient
oxidized form
hypnotic agent
containing
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2111566A
Inventor
Kazuki Honda
Shojiro Inoue
Yasuo Komoda
Original Assignee
Yasuo Komoda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yasuo Komoda filed Critical Yasuo Komoda
Priority to JP2111566A priority Critical patent/JPH049336A/en
Publication of JPH049336A publication Critical patent/JPH049336A/en
Application status is Pending legal-status Critical

Links

Abstract

PURPOSE: To obtain a hypnotic agent, containing an oxidized form glutathione as an active ingredient and assuming significant sleep promoting action.
CONSTITUTION: A hypnopic agent containing an oxidized form glutathione (γ-glutamuylcysteinylglycine disulfide), known as a crystalline polypeptide separated from living bodies and expressed by the formula as an active ingredient. The dose of the aforementioned compound is within the range of 1-80mg at a time.
COPYRIGHT: (C)1992,JPO&Japio
JP2111566A 1990-04-26 1990-04-26 Hypnotic agent Pending JPH049336A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2111566A JPH049336A (en) 1990-04-26 1990-04-26 Hypnotic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2111566A JPH049336A (en) 1990-04-26 1990-04-26 Hypnotic agent

Publications (1)

Publication Number Publication Date
JPH049336A true JPH049336A (en) 1992-01-14

Family

ID=14564627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2111566A Pending JPH049336A (en) 1990-04-26 1990-04-26 Hypnotic agent

Country Status (1)

Country Link
JP (1) JPH049336A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833935A (en) * 1994-01-28 1998-11-10 Steris Corporation Microbial decontamination system with components porous to anti-microbial fluids
US6165979A (en) * 1995-12-14 2000-12-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
US6251857B1 (en) * 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
US7169412B2 (en) 1998-11-23 2007-01-30 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
JP2007055962A (en) * 2005-08-26 2007-03-08 Kohjin Co Ltd Oral hypnotic and hypnotic food or drink
JP2008056628A (en) * 2006-09-01 2008-03-13 Fancl Corp Sleep inducer and stress insomnia ameliorating agent
US7371411B2 (en) 1998-11-23 2008-05-13 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
US8828955B2 (en) 2008-05-09 2014-09-09 Maruzen Pharmaceuticals Co., Ltd. Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833935A (en) * 1994-01-28 1998-11-10 Steris Corporation Microbial decontamination system with components porous to anti-microbial fluids
US6165979A (en) * 1995-12-14 2000-12-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
US6251857B1 (en) * 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
US6492329B1 (en) 1995-12-14 2002-12-10 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
US7169412B2 (en) 1998-11-23 2007-01-30 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
US7371411B2 (en) 1998-11-23 2008-05-13 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
JP2007055962A (en) * 2005-08-26 2007-03-08 Kohjin Co Ltd Oral hypnotic and hypnotic food or drink
JP2008056628A (en) * 2006-09-01 2008-03-13 Fancl Corp Sleep inducer and stress insomnia ameliorating agent
US8828955B2 (en) 2008-05-09 2014-09-09 Maruzen Pharmaceuticals Co., Ltd. Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed

Similar Documents

Publication Publication Date Title
JPS60208965A (en) Novel carbostyril derivative and its preparation
JPS5334794A (en) Cephalosporin derivatives and their preparation
NZ245658A (en) Microencapsulated pharmaceutical compositions where the active ingredient is present as the anhydrate of its base form, preparation thereof
JPS6326756B2 (en)
JPH035451A (en) Pesticide and its preparation
CA2041168A1 (en) Use of alkylcarboxylic acid dimethylamides as crystallization inhibitors
HUT61435A (en) Pesticidal and fungicidal composition comprising phenylacrylic acid derivatives and process for producing and using the active ingredients
JPS6354321A (en) Blood sugar lowering agent
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
CA2078019A1 (en) Substance or composition and uses thereof
JPH0215029A (en) Quinolidinone compound or antiulcer agent containing salt thereof
EP0270362A3 (en) Pyridinylpyrimidine derivatives, method for production thereof and a fungicide containing them as the active ingredient
JPS53119844A (en) Optically active amino acid-mandelic acid complexes and theire preparation
JPH04226914A (en) Baclofen for treatment of angina pectoris
JPS5513275A (en) Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it
JPS5412372A (en) Thiazolidine derivative and its preparation
JPH0276803A (en) Herbicidal composition
HUT57548A (en) Insecticidal and acaricidal compositions comprising new murpholinourea derivatives as active ingredient and process for producing the active ingredients
JPH04235107A (en) Bactericidal and antibacterial agent
CA2103590A1 (en) Benzamide derivative
JPH04264033A (en) O/w type emulsion nutritional composition
JPS6396126A (en) Stabilized composition
JPH04243825A (en) Remedy for pigmentation
EP0353821A3 (en) Antipsychotic 3-piperazinyl-benzazole derivatives
JPH0240325A (en) Pharmaceutical compound